Innovent Biologics
1801.HK
#1227
Rank
โ‚น1.656 T
Marketcap
โ‚น949.77
Share price
-6.26%
Change (1 day)
-6.83%
Change (1 year)

Revenue for Innovent Biologics (1801.HK)

Revenue in 2025: โ‚น173.41 Billion

According to Innovent Biologics's latest financial reports the company's current revenue (TTM ) is โ‚น173.41 Billion. In 2025 the company made a revenue of โ‚น173.41 Billion an increase over the revenue in the year 2024 that were of โ‚น120.10 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Innovent Biologics from 2016 to 2025

Annual revenue

Year Revenue Change
2025โ‚น173.41 B44.39%
2024โ‚น120.10 B47.04%
2023โ‚น81.67 B32.9%
2022โ‚น61.45 B-1.41%
2021โ‚น62.33 B13.7%
2020โ‚น54.82 B293.02%
2019โ‚น13.95 B10781.66%
2018โ‚น0.12 B-51.64%
2017โ‚น0.26 B
2016N/A